The Effect of Dexmedetomidine and Midazolam on Hemodynamic Indices During Anesthesia
Phase 2
- Conditions
- General Anesthesia.Other complications of anesthesiaT88.5
- Registration Number
- IRCT20110528006617N3
- Lead Sponsor
- Esfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
Age between 20 and 70 years
Patients who consent to the informed consent to participate in the study.
Exclusion Criteria
Patients who are not allergic to anesthetic drugs.
Patients who do not take anti hypertensive drugs to control their blood pressure.
Patients who do not receive the Nimodipin drug due to hemorrhage of the subaracnoide.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Systolic blood pressure. Timepoint: Before intervention and 1 , 2 , 3 min after intervention. Method of measurement: mm-hg, sphygmomanometer.;Diastolic bllod pressure. Timepoint: Before intervention and 1 , 2 , 3 min after intervention. Method of measurement: mm-hg, sphygmomanometer.;Mean arterial pressure. Timepoint: Before intervention and 1 , 2 , 3 min after intervention. Method of measurement: mm-hg, sphygmomanometer.;Heart rate. Timepoint: Before intervention and 1 , 2 , 3 min after intervention. Method of measurement: ECG monitor.
- Secondary Outcome Measures
Name Time Method Hypotension. Timepoint: Before intervention and 1 , 2 , 3 min after intervention. Method of measurement: mm-Hg, sphygmomanometer.;Hypertension. Timepoint: Before intervention and 1 , 2 , 3 min after intervention. Method of measurement: mm-Hg, sphygmomanometer.;Tachycardia. Timepoint: Before intervention and 1 , 2 , 3 min after intervention. Method of measurement: ECG monitor.;Bradycardia. Timepoint: Before intervention and 1 , 2 , 3 min after intervention. Method of measurement: ECG monitor.